Fibrocalculous Pancreatic Diabetes: (FCPD)
A most common form of diabetes worldwide is Type 1 and Type 2 diabetes. Fibrocalculous pancreatic diabetes (FCPD) is a unique form of diabetes,...
Type: Image
Dr Faraz Farishta: a Rare Case of Hyperinsulinemic Hypoglycemia (Hirata’s Disease (IAH))
CASE OVERVIEW Insulin Autoimmune Syndrome (IAS)/ Hirata’s Disease (IAH) is a rare cause of hypoglycemia. Such case of 70-year old female was presented by...
Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg vs 1.0 mg by Baseline HbA1c and BMI: SUSTAIN FORTE Subgroup Analyses
Once-weekly (OW) subcutaneous semaglutide is a GLP-1RA supported for the treatment of type 2 diabetes (T2D) at dosages of 0.5 mg and 1.0 mg....
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial
Weight loss proves to be beneficial for patients with diabetes. A combination of lifestyle intervention, behavioral modifications and pharmacotherapy helps improve various cardio-metabolic risk...
Highlights in ADA 2021 for Diabetes Technologies and Therapeutics
The American Diabetes Association (ADA) Annual Meetings provide great opportunities to the whole diabetes community for networking, collaboration, and learning updates in the field...
A comparative effectiveness study of major glycemia-lowering medication for T2DM treatment
There has been an increase in glucose-lowering medications with an increase in the prevalence of diabetes worldwide. Hence a GRADE study was conducted under...
